Literature DB >> 17984131

When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?

Roland R J van Kimmenade, Yigal Pinto, James L Januzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17984131     DOI： 10.1093/eurheartj/ehl399

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation.

Authors:  Jingjun Lu; Xianwei Wang; Wenze Wang; Harish Muniyappa; Abhishek Deshmukh; Changping Hu; Kumuda Das; Jawahar L Mehta
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

2.  Natriuretic peptides in chronic kidney disease.

Authors:  Rajat Tagore; Lieng H Ling; Hong Yang; Hla-Yee Daw; Yiong-Huak Chan; Sunil K Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 8.237

Review 3.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

4.  B-type natriuretic peptide predicts long-term prognosis in a cohort of critically ill patients.

Authors:  Rui Baptista; Elisabete Jorge; Eduardo Sousa; Jorge Pimentel
Journal:  Heart Int       Date:  2011-10-21

5.  Left atrial volume index and aortic stiffness index in adult hemodialysed patients--link between compliance and pressure mediated by endothelium dysfunction; a cross-sectional study.

Authors:  Tomasz Zapolski; Andrzej Wysokiński; Andrzej Książek; Andrzej Jaroszyński
Journal:  BMC Cardiovasc Disord       Date:  2012-11-05       Impact factor: 2.298
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.